Making Science Group (FRA:MS7) 5-Year EBITDA Growth Rate: 16.40% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MS7 Making Science Group SA FRA:MS7
61 GF Score
Price €6.15
GF Value €12.15
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Making Science Group 5-Year EBITDA Growth Rate?

Making Science Group FRA:MS7 -8.21% 61 5-Year EBITDA Growth Rate is 16.40% as of Dec. 2025. GuruFocus rates FRA:MS7 with a GF Score™ of 61/100 and a GF Value™ of €12.15 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Making Science Group's EBITDA per Share for the six months ended in Dec. 2025 was €-0.05.

During the past 12 months, Making Science Group's average EBITDA Per Share Growth Rate was -52.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -12.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 16.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Making Science Group was 66.70% per year. The lowest was -12.70% per year. And the median was 42.40% per year.


Making Science Group  (FRA:MS7) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Making Science Group 5-Year EBITDA Growth Rate Related Terms


FRA:MS7 vs APP, OMC, TTD: 5-Year EBITDA Growth Rate Comparison

For the Advertising Agencies subindustry, Making Science Group's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Making Science Group 5-Year EBITDA Growth Rate vs Media - Diversified Industry

For the Media - Diversified industry and Communication Services sector, Making Science Group's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Making Science Group's 5-Year EBITDA Growth Rate falls into.


FRA:MS7
61GF Score
Making Science Group SA FRA:MS7
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Making Science Group 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 16.40% mean?
Making Science Group (FRA:MS7) has a 5-Year EBITDA Growth Rate of 16.40% as of Dec. 2025. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Making Science Group and its competitors.
Is Making Science Group's 5-Year EBITDA Growth Rate too high?
Making Science Group's current 5-Year EBITDA Growth Rate is 16.40%. Overall, Making Science Group has a GF Score™ of 61/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Making Science Group's 5-Year EBITDA Growth Rate compare to APP and OMC?
Making Science Group's 5-Year EBITDA Growth Rate of 16.40% can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Media - Diversified company?
A good 5-Year EBITDA Growth Rate depends on the Media - Diversified industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Making Science Group and its competitors. Making Science Group's current 5-Year EBITDA Growth Rate is 16.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Making Science Group stock overvalued right now?
Based on GuruFocus' analysis, Making Science Group (FRA:MS7) is currently considered Significantly Undervalued. The stock's GF Value™ is €12.15, compared to a current price of €6.15 — trading 49.4% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 16.40%. Making Science Group's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Making Science Group (FRA:MS7), the current 5-Year EBITDA Growth Rate is 16.40% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Making Science Group (FRA:MS7) Overvalued in 2026?

Based on GuruFocus' analysis, Making Science Group stock appears to be undervalued. The current stock price of €6.15 is trading 49.4% below its estimated GF Value™ of €12.15. GuruFocus considers Making Science Group to be Significantly Undervalued.

Key valuation signals for FRA:MS7:

  • 5-Year EBITDA Growth Rate: 16.40%
  • GF Value™: €12.15 vs. price of €6.15 (49.4% below fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the FRA:MS7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Making Science Group Business Description

Other Exchanges ALMKS:FranceMAKS:Spain
Address Calle Lopez de Hoyos 135, Madrid, ESP, 28002
Making Science Group SA is engaged in the business of technology and marketing solutions for the e-commerce and digital transformation business. The company provides solutions in the areas of digital marketing, data analytics, e-commerce, and cloud. The company carries out its professional activity in the United States, Spain, Italy, France, and other. The company obtains its income mainly from advertising and public relations services. The business segments are: Spain; International; and E-commerce and Product. The Spain and International segments, the business lines are Media and Digital Marketing, Cloud Solutions, Software & Cybersecurity, and proprietary Adtech technology. The E-commerce and Product segment focuses on the Marketplace and E-commerce business lines.
61GF Score

Get the complete analysis for FRA:MS7

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.15
Price
€12.15
GF Value